Position in AXSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,420,508
+$5,283,989 QoQ
Shares Held
63,000
+13.5% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#101
of 500 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Sep 30, 2022CallValue
$55,774
CallShares
1,250
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $138,478,275 across 17 Biotechnology names. AXSM ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
88,000 | $16,480,639 | |
| 2 | ASND |
Ascendis Pharma A/S
|
61,000 | $16,269,919 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
165,000 | $16,084,198 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
This page
|
63,000 | $15,420,508 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
104,000 | $11,925,678 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
272,000 | $10,526,399 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
100,000 | $9,516,998 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
217,000 | $7,679,628 |
All Filings in AXSM
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,420,508 | 63,000 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $10,136,519 | 55,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,951,049 | 49,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,814,570 | 46,121 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $8,595,630 | 73,700 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,861,419 | 22,000 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,122,589 | 57,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,944,500 | 49,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,426,399 | 68,000 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,308,651 | 66,700 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,962,189 | 71,000 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,048,319 | 112,000 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,560,399 | 155,000 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $17,472,643 | 226,535 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,794,403 | 264,330 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $55,774 | 1,250 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $5,744,999 | 150,000 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $38,299 | 1,000 | Call | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||